PRMT5 and pancreatic neoplasm: They found that PRMT5 posttranslationally regulated c‐Myc stability via the E3 ubiquitin ligase FBW7, which controlled c‐Myc degradation, thus increasing c‐Myc levels and leading to the subsequent enhanced proliferation and aerobic glycolysis in pancreatic cancer cells.